IN8BIO, INC. (INAB) Operating cash flow 2020–2025
IN8BIO, INC. (INAB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.7MFY2025 · since FY2020: -$7.1M → -$12.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.7M | +47.4% |
| FY2024 | -$24.1M | -3.5% |
| FY2023 | -$23.3M | +3.2% |
| FY2022 | -$24.1M | -78.6% |
| FY2021 | -$13.5M | -89.4% |
| FY2020 | -$7.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More INAB financial trends
INAB RevenueINAB Net incomeINAB Net marginINAB Gross profitINAB Gross marginINAB Operating incomeINAB Operating marginINAB Free cash flowINAB Capital expendituresINAB Return on equityINAB Stock buybacksINAB Dividends paidINAB Total assetsINAB Total liabilitiesINAB Shareholders’ equityINAB overview →